Diacomit

Product manufactured by Biocodex, Inc.

Application Nr Approved Date Route Status External Links
NDA206709 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Diacomit Is Indicated For The Treatment Of Seizures Associated With Dravet Syndrome (Ds) In Patients 2 Years Of Age And Older Taking Clobazam. There Are No Clinical Data To Support The Use Of Diacomit As Monotherapy In Dravet Syndrome. Diacomit Is Indicated For The Treatment Of Seizures Associated With Dravet Syndrome In Patients 2 Years Of Age And Older Taking Clobazam. There Are No Clinical Data To Support The Use Of Diacomit As Monotherapy In Dravet Syndrome. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Stiripentol STIRIPENTOL ZINC724

Comments